Serum Institute asks Joe Biden to lift embargo on raw material exports for ramping up Covid-19 vaccine production

Published On 2021-04-17 07:21 GMT   |   Update On 2021-04-17 07:29 GMT

New Delhi: The Serum Institute of India (SII), the world's biggest vaccine maker, on Friday urged U.S. President Joe Biden to lift an embargo on U.S. exports of raw materials that is hurting its production of COVID-19 shots.

"Respected @POTUS, if we are to truly unite in beating this virus, on behalf of the vaccine industry outside the U.S., I humbly request you to lift the embargo of raw material exports out of the U.S. so that vaccine production can ramp up," SII Chief Executive Adar Poonawalla said in a tweet.

Read also: Serum Institute Legally Compelled To Ship Covid-19 Vaccine: COVAX

SII is making the AstraZeneca shot for the world and will soon start producing the Novavax vaccine.

Read also: Serum Instit    ute refunds South Africa for 5 lakh undelivered doses of COVID vaccine



Tags:    
Article Source : Reuters

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News